Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LONGDAPTPAD: Long vs Short DAPT in PAD
NCT02798913Phase 3Unknown
- Sponsor
- University of Naples Federico II
- Start
- Jan 2016
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in peripheral artery disease (PAD), sponsored by University of Naples Federico II. Status: unknown.
02
Drugs
clopidogrel
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT02798913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798913.